Vaccine Development

Vaccine Recommendations Funding Issues Funding Cuts COVID-19 Vaccines Public Health

GSK Secures $370 Million After CureVac US Patent Settlement

The settlement grants BioNTech and Pfizer licences for mRNA Covid and influenza vaccines with a $130 million contingent payment tied to BioNTech’s planned takeover of CureVac

9 ARTICLES

3w ago

U.S. Ends $500 Million in BARDA mRNA Vaccine Funding